Literature DB >> 17950244

PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.

Gang Zheng1, Jinying Ning, Yu-Chung Yang.   

Abstract

PLAGL2 (Pleomorphic Adenoma Gene Like 2) is an oncoprotein involved in various malignancies including lipoblastomas, hepatoblastomas, and acute myeloid leukemia. Although PLAGL2 is known to mainly act as a transcription factor, other functions which may contribute to its oncogenic potential are not clear. Pirh2 (P53 induced RING-H2 protein) is a p53 inducible E3 ligase involved in the ubiquitination of p53, while the mechanisms to regulate its activities are largely unknown. In this study, we show for the first time that Pirh2 forms dimers through its N- and C-terminus in cells and Pirh2 dimers interact with PLAGL2. The interaction between PLAGL2 and Pirh2 dimers prevents proteasomal degradation of Pirh2. This study thus uncovers a novel function of PLAGL2 as an oncoprotein through regulating the stability of Pirh2. Given the importance of Pirh2 in regulating p53 stability, its interaction with PLAGL2 may provide valuable therapeutic targets in treating Pirh2-overexpression malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950244      PMCID: PMC2708094          DOI: 10.1016/j.bbrc.2007.10.003

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

2.  Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.

Authors:  A K Aström; M L Voz; K Kas; E Röijer; B Wedell; N Mandahl; W Van de Ven; J Mark; G Stenman
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

3.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

4.  An inducible nitric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity.

Authors:  E A Ratovitski; C Bao; R A Quick; A McMillan; C Kozlovsky; C J Lowenstein
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

5.  Transcriptional activation capacity of the novel PLAG family of zinc finger proteins.

Authors:  K Kas; M L Voz; K Hensen; E Meyen; W J Van de Ven
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

6.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; R D Vierstra; P M Howley
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

7.  Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability.

Authors:  Q A Albakri; D J Stuehr
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

8.  Degradation signal masking by heterodimerization of MATalpha2 and MATa1 blocks their mutual destruction by the ubiquitin-proteasome pathway.

Authors:  P R Johnson; R Swanson; L Rakhilina; M Hochstrasser
Journal:  Cell       Date:  1998-07-24       Impact factor: 41.582

9.  Yin Yang 1 is a negative regulator of p53.

Authors:  Guangchao Sui; El Bachir Affar; Yujiang Shi; Chrystelle Brignone; Nathan R Wall; Peng Yin; Mary Donohoe; Margaret P Luke; Dominica Calvo; Steven R Grossman; Yang Shi
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

10.  Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer.

Authors:  Wenrui Duan; Li Gao; Lawrence J Druhan; Wei-Guo Zhu; Carl Morrison; Gregory A Otterson; Miguel A Villalona-Calero
Journal:  J Natl Cancer Inst       Date:  2004-11-17       Impact factor: 13.506

View more
  15 in total

1.  Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.

Authors:  Lan Wang; Guifen He; Pingzhao Zhang; Xiang Wang; Mei Jiang; Long Yu
Journal:  Mol Biol Rep       Date:  2010-03-24       Impact factor: 2.316

2.  Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.

Authors:  Chad A Corcoran; JoAnne Montalbano; Hong Sun; Qin He; Ying Huang; M Saeed Sheikh
Journal:  J Biol Chem       Date:  2009-05-29       Impact factor: 5.157

3.  PI4Kγ2 Interacts with E3 Ligase MIEL1 to Regulate Auxin Metabolism and Root Development.

Authors:  Chun-Yan Zhao; Hong-Wei Xue
Journal:  Plant Physiol       Date:  2020-08-11       Impact factor: 8.340

Review 4.  Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  FEBS Lett       Date:  2012-04-03       Impact factor: 4.124

Review 5.  The Role of E3 Ligase Pirh2 in Disease.

Authors:  Alexandra Daks; Olga Fedorova; Sergey Parfenyev; Ivan Nevzorov; Oleg Shuvalov; Nickolai A Barlev
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

6.  Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.

Authors:  Yong-Sam Jung; Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

7.  PLAGL2 expression-induced lung epithelium damages at bronchiolar alveolar duct junction in emphysema: bNip3- and SP-C-associated cell death/injury activity.

Authors:  Yih-Sheng Yang; Meng-Chun W Yang; Yuhong Guo; Olatunji W Williams; Jonathan C Weissler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-02       Impact factor: 5.464

8.  The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis.

Authors:  Bo Liu; Chong Lu; Yong-Xi Song; Peng Gao; Jing-Xu Sun; Xiao-Wan Chen; Mei-Xian Wang; Yu-Lan Dong; Hui-Mian Xu; Zhen-Ning Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

9.  Systems Biomedicine of Primary and Metastatic Colorectal Cancer Reveals Potential Therapeutic Targets.

Authors:  Mehran Piran; Neda Sepahi; Afagh Moattari; Amir Rahimi; Ali Ghanbariasad
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

10.  The homeodomain transcription factor Hoxa2 interacts with and promotes the proteasomal degradation of the E3 ubiquitin protein ligase RCHY1.

Authors:  Isabelle Bergiers; Laure Bridoux; Nathan Nguyen; Jean-Claude Twizere; René Rezsöhazy
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.